⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGNX News
MacroGenics, Inc.
Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes
globenewswire.com
PFE
LLY
MGNX
LGND
Maxon marque son entrée officielle sur le marché AEC avec sa solution Archviz en temps réel
accessnewswire.com
ADSK
MGNX
MediQuant Expands Enterprise Archiving Platform to Help Health Systems Optimize Applications and Activate Legacy Clinical Data
accessnewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics to Participate in Upcoming Investor Conferences
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
globenewswire.com
MGNX
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
MGNX
IMTX
LLY
PFE